Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
GlobeNewswire
Policy change comes quickly after FDA clearance for NeuroStar TMS use in ages 15 and older
MALVERN, Pa., May 15, 2024..
Policy change comes quickly after FDA clearance for NeuroStar TMS use in ages 15 and older
MALVERN, Pa., May 15, 2024..
Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024Recorded Positive Quarterly Net Income for Second Consecutive..
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company..